Maternal iron metabolism gene variants modify umbilical cord blood lead levels by gene-environment interaction: A birth cohort study

Environmental Health: A Global Access Science Source

Volumn 13, Issue 1, 2014, Pages

  Karwowski, Mateusz P ^a,b   Just, Allan C ^b   Bellinger, David C ^a,b   Jim, Rebecca ^c   Hatley, Earl L ^c   Ettinger, Adrienne S ^d   Hu, Howard ^e   Wright, Robert O ^f  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Local Environmental Action Demanded (LEAD) Agency   (United States)

^d Center for Perinatal   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

C282Y; H63D; Hemochromatosis gene; Lead; P570S; Pediatric; Polymorphism; Prenatal; Transferrin gene

Indexed keywords

HFE PROTEIN; IRON; LEAD; TRANSFERRIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

BLOOD; CHILD HEALTH; GENE EXPRESSION; GENE TRANSFER; GENOTYPE-ENVIRONMENT INTERACTION; IRON; LEAD; METABOLISM; NUMERICAL MODEL; POLYMORPHISM; PROTEIN; RISK ASSESSMENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HARDY WEINBERG EQUILIBRIUM; HEMATOCRIT; HFE GENE; HUMAN; INFANT; IRON METABOLISM; LEAD BLOOD LEVEL; MALE; MATERNAL BLOOD; NEWBORN; PLACENTAL TRANSFER; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TF GENE; UMBILICAL CORD BLOOD; UNITED STATES; YOUNG ADULT; CHEMISTRY; FETUS BLOOD; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MISSENSE MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; OKLAHOMA; STATISTICAL MODEL;

COHORT STUDIES; FEMALE; FETAL BLOOD; GENE-ENVIRONMENT INTERACTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFANT, NEWBORN; IRON; LINEAR MODELS; MALE; MEMBRANE PROTEINS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION, MISSENSE; OKLAHOMA; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFERRIN;

EID: 84988725305     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-13-77     Document Type: Article

References (46)

1. National Center for Environmental Health: Division of Emergency and Environmental Health Services: Guidelines for the Identification and Management of Lead Exposure in Pregnancy and Lactating Women. Atlanta: U.S. Department of Health and Human Services; 2010.
2. Age and sex composition in the United States. 2010 [https://www.census. gov/population/age/data/2010comp.html]
3. Lead: standard surveillance definitions and classifications. [http://www. cdc.gov/nceh/lead/data/definitions.htm]
4. Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention: A Review of Evidence of Health Effects of Blood Lead Levels <10 μg/dl in Children Atlanta U.S Department of Health and Human Services 2004
5. Gundacker C, Hengstschlager M: The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr 2012, 162:201-206.
6. Jauniaux E, Gulbis B, Burton GJ: The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus-A review. Placenta 2003, 24(24 Suppl A):S86-S93.
7. Hertz-Picciotto I: The evidence that lead increases the risk for spontaneous abortion. Am J Ind Med 2000, 38:300-309.
8. Irgens A, Kruger K, Skorve AH, Irgens LM: Reproductive outcome in offspring of parents occupationally exposed to lead in Norway. Am J Ind Med 1998, 34:431-437.
9. Andrews KW, Savitz DA, Hertz-Picciotto I: Prenatal lead exposure in relation to gestational age and birth weight: A review of epidemiologic studies. Am J Ind Med 1994, 26:13-32.
10. Chen PC, Pan IJ, Wang JD: Parental exposure to lead and small for gestational age births. Am J Ind Med 2006, 49:417-422.
11. Needleman HL, Rabinowitz M, Leviton A, Linn S, Schoenbaum S: The relationship between prenatal exposure to lead and congenital anomalies. JAMA 1984, 251:2956-2959.
12. Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M: Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol 1986, 8:151-161.
13. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M: Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987, 316:1037-1043.
14. Dietrich KN, Krafft KM, Bornscein RL, Hammond PB, Berger O, Succop PA, Bier M: Low-level fetal exposure effect on neurobehavioral development in early infancy. Pediatrics 1987, 80:721-730.
15. Shen XM, Yan CH, Guo D, Wu SM, Li RQ, Huang H, Ao LM, Zhou JD, Hong ZY, Xu JD, Jin XM, Tang JM: Low-level prenatal lead exposure and neurobehavioral development of children in the first year of life: A prospective study in Shanghai. Environ Res 1998, 79:1-8.
16. Aisen P: Transferrin, the transferrin receptor, and the uptake of iron by cells. Met Ions Biol Syst 1998, 35:585-631.
17. Lee PL, Ho NJ, Olson R, Beutler E: The effect of transferrin polymorphisms on iron metabolism. Blood Cells Mol Dis 1999, 25:374-379.
18. Basclain KA, Shilkin KB, Withers G, Reed WD, Jeffrey GP: Cellular expression and regulation of iron transport and storage proteins in genetic haemochromatosis. J Gastroenterol Hepatol 1998, 13:624-634.
19. Fleming RE, Migas MC, Zhou X, Jiang J, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, Sly WS: Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci U S A 1999, 96:3143-3148.
20. Zoller H, Pietrangelo A, Vogel W, Weiss G: Duodenal metal-Transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 1999, 353:2120-2123.
21. Acton RT, Barton JC, Snively BM, McLaren CE, Adams PC, Harris EL, Speechley MR, McLaren GD, Dawkins FW, Leiendecker-Foster C, Holup JL, Balasubramanyam A: Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Ethn Dis 2006, 16:815-821.
22. Hopkins MR, Ettinger AS, Hernandez-Avila M, Schwartz J, Tellez-Rojo MM, Lamadrid-Figueroa H, Bellinger D, Hu H, Wright RO: Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect 2008, 116:1261-1266.
23. Wright RO, Silverman EK, Schwartz J, Tsaih SW, Senter J, Sparrow D, Weiss ST, Aro A, Hu H: Association between hemochromatosis genotype and lead exposure among elderly men: The normative aging study. Environ Health Perspect 2004, 112:746-750.
24. Wang FT, Hu H, Schwartz J, Weuve J, Spiro AS, Sparrow D, Nie H, Silverman EK, Weiss ST, Wright RO: Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environ Health Perspect 2007, 115:1210-1215.
25. Park SK, Hu H, Wright RO, Schwartz J, Cheng Y, Sparrow D, Vokonas PS, Weisskopf MG: Iron metabolism genes, low-level lead exposure, and QT interval. Environ Health Perspect 2009, 117:80-85.
26. Bridges CC, Zalups RK: Molecular and ionic mimicry and the transport of toxic metals. Toxicol Appl Pharmacol 2005, 204:274-308.
27. Roy A, Ettinger AS, Hu H, Bellinger D, Schwartz J, Modali R, Wright RO, Palaniappan K, Balakrishnan K: Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ. Neurotoxicology 2013, 38C:17-22.
28. Cantonwine D, Hu H, Tellez-Rojo MM, Sanchez BN, Lamadrid-Figueroa H, Ettinger AS, Mercado-Garcia A, Hernandez-Avila M, Wright RO: HFE gene variants modify the association between maternal lead burden and infant birthweight: A prospective birth cohort study in Mexico City. Mexico Environ Health 2010, 9:43.
29. Zhang A, Park SK, Wright RO, Weisskopf MG, Mukherjee B, Nie H, Sparrow D, Hu H: HFE H63D polymorphism as a modifier of the effect of cumulative lead exposure on pulse pressure: The Normative Aging Study. Environ Health Perspect 2010, 118:1261-1266.
30. Hu H, Shine J, Wright RO: The challenge posed to children's health by mixtures of toxic waste: The Tar Creek superfund site as a case-study. Pediatr Clin North Am 2007, 54:155-175. x.
31. Grummer-Strawn LM, Reinold CM, Krebs NF, National Center for Chronic Disease Prevention and Health Promotion (U.S.), Centers for Disease Control and Prevention (U.S.): Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. In MMWR Morbidity and Mortality Weekly Report Recommendations and Reports. 2010:15.
32. Onalaja AO, Claudio L: Genetic susceptibility to lead poisoning. Environ Health Perspect 2000, 108(Suppl 1):23-28.
33. Chaparro CM, Fornes R, Neufeld LM, Tena Alavez G, Eguia-Liz Cedillo R, Dewey KG: Early umbilical cord clamping contributes to elevated blood lead levels among infants with higher lead exposure. J Pediatr 2007, 151:506-512.
34. Lin C, Doyle P, Wang D, Hwang Y-H, Chen P-C: The role of essential metals in the placental transfer of lead from mother to child. Reprod Toxicol 2010, 29:443-446.
35. Al-Saleh I, Shinwari N, Mashhour A, Mohamed Gel D, Rabah A: Heavy metals (lead, cadmium and mercury) in maternal, cord blood and placenta of healthy women. Int J Hyg Environ Health 2011, 214:79-101.
36. Osman K, Akesson A, Berglund M, Bremme K, Schutz A, Ask K, Vahter M: Toxic and essential elements in placentas of Swedish women. Clin Biochem 2000, 33:131-138.
37. Goyer RA: Transplacental transport of lead. Environ Health Perspect 1990, 89:101-105.
38. Parkkila S, Waheed A, Britton RS, Bacon BR, Zhou XY, Tomatsu S, Fleming RE, Sly WS: Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 1997, 94:13198-13202.
39. Bressler JP, Olivi L, Cheong JH, Kim Y, Bannona D: Divalent metal transporter 1 in lead and cadmium transport. Ann N Y Acad Sci 2004, 1012:142-152.
40. Georgieff MK, Wobken JK, Welle J, Burdo JR, Connor JR: Identification and localization of divalent metal transporter-1 (DMT-1) in term human placenta. Placenta 2000, 21:799-804.
41. Chong WS, Kwan PC, Chan LY, Chiu PY, Cheung TK, Lau TK: Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester human placenta and embryonic tissues. Hum Reprod 2005, 20:3532-3538.
42. Li YQ, Bai B, Cao XX, Zhang YH, Yan H, Zheng QQ, Zhuang GH: Divalent metal transporter 1 expression and regulation in human placenta. Biol Trace Elem Res 2012, 146:6-12.
43. Aschner M, Syversen T, Souza DO, Rocha JB: Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity. Exp Biol Med (Maywood) 2006, 231:1468-1473.
44. Gundacker C, Gencik M, Hengstschlager M: The relevance of the individual genetic background for the toxicokinetics of two significant neurodevelopmental toxicants: mercury and lead. Mutat Res 2010, 705:130-140.
45. Goyer RA, Haust MD, Cherian MG: Cellular localization of metallothionein in human term placenta. Placenta 1992, 13:349-355.
46. Zhang AS, Enns CA: Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program 2009, 1:207-214.